Evaluation of Efficacy, Safety, and Tolerability of Povetacicept in Participants With Primary Membranous Nephropathy (pMN)
for Primary Membranous Nephropathy
22 locations incl. Montgomery
Sponsor: Vertex Pharmaceuticals Incorporated
Sex: All·Age: 18 - 75
Code: NCT07204275·Phase 2, Phase 3·Recruiting